Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 280.00 GBp
Change Today +1.25 / 0.45%
Volume 56.2K
SKP On Other Exchanges
Symbol
Exchange
London
OTC US
OTC US
Frankfurt
As of 11:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Keith Mansford M.Sc., Ph.D., F.R.S.C., F.I.Biol., C.Chem., C.Biol

Former Non-Executive Director and Member of Remuneration Committee, Skyepharma PLC
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 6 different industries.

See Board Relationships
83--

Background*

Keith Mansford, M.Sc., Ph.D., F.R.S.C., F.I.Biol., C.Chem., C.Biol., D.I.C, is the Founder and Principle of Mansford Associates and has been its President since 1992. Dr. Mansford is a Professor of Biochemistry at the University of BuckinghamBuckingham's Clore Laboratory, where the research group specializes in receptor, cell based and animal models of metabolic diseases including Type II Diabetes and Obesity. From 1984 to 1992, Dr. Mansford served as Chairman of Research ...

Read Full Background

Corporate Headquarters*

46-48 Grosvenor Gardens
London, Greater London SW1W 0EB

United Kingdom

Phone: 44 20 7881 0524
Fax: 44 20 7881 1199

Board Members Memberships*

Director

Education*

PhD
University Of London
MS
Durham University
BS
Durham University
PhD
Imperial College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKP:LN 280.00 GBp +1.25

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€424.3K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$751.4K
Aijaz Tobaccowalla Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee
Pfizer Limited
52.4M
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYEPHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.